In critically appraising the applicability of a study to your patient population, which factor is most informative?

In critically appraising the applicability of a study to your patient population, which factor is most informative?

• A. Study design quality, including control of bias.
• B. Representativeness of the sample to the target population.
• C. Journal impact factor.
• D. Length of the abstract.

Answer: (B)

Assessing whether study results apply to your patient population hinges on external validity—the extent to which findings can be generalized beyond the study sample. The most informative factor is how representative the study participants are of the target population you care for. If the sample mirrors your patients in key aspects—age, sex, race/ethnicity, disease severity, comorbidities, and the care setting—then the observed effects are more likely to hold true in practice. In contrast, a rigorously conducted study can still be of limited use for your patients if the participants come from a very different or narrow group (for example, a trial enrolling mostly younger, healthier individuals or those in a specialized clinic). Internal validity, reflected in study design quality and control of bias, matters for how trustworthy the results are, but it doesn’t by itself guarantee applicability to your population. Journal impact factor and the length of the abstract don’t provide reliable information about whether the findings will translate to your patients.

Assessing whether study results apply to your patient population hinges on external validity—the extent to which findings can be generalized beyond the study sample. The most informative factor is how representative the study participants are of the target population you care for. If the sample mirrors your patients in key aspects—age, sex, race/ethnicity, disease severity, comorbidities, and the care setting—then the observed effects are more likely to hold true in practice. In contrast, a rigorously conducted study can still be of limited use for your patients if the participants come from a very different or narrow group (for example, a trial enrolling mostly younger, healthier individuals or those in a specialized clinic).

Internal validity, reflected in study design quality and control of bias, matters for how trustworthy the results are, but it doesn’t by itself guarantee applicability to your population. Journal impact factor and the length of the abstract don’t provide reliable information about whether the findings will translate to your patients.